Home > News > BioSante Pharmaceuticals Presents New Anthrax Vaccine Data
March 22nd, 2006
BioSante Pharmaceuticals Presents New Anthrax Vaccine Data
Abstract:
Dr. Steve Bell, vice president of research and pre-clinical development for BioSante, will present the new findings in a case study report on the ongoing research and development of a next generation needle-free anthrax (rPA) vaccine using BioVant(TM), the company's patented calcium phosphate (CaP) nanoparticulate technology.
Source:
genengnews.com
Bookmark:
Nanomedicine
Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013
Iranian Scientists Produce Dynamometer for Nanoparticles, Biocells June 15th, 2013
Monell-led research identifies scent of melanoma: New research may lead to early non-invasive detection and diagnosis June 14th, 2013
Discovery of new material state counterintuitive to laws of physics June 14th, 2013
Announcements
An Innovative material for the Green Earth: Simple and inexpensive process to make a material for CO2 adsorption June 17th, 2013
Polymer-coated catalyst protects "artificial leaf" June 17th, 2013
Efficient and inexpensive: Researchers develop catalyst material for fuel cells: Platinum-nickel nano-octahedra save 90 percent platinum June 17th, 2013
AXEON Acquires Assets of Leading Reverse Osmosis Systems Manufacturer June 17th, 2013